• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors.

作者信息

Hwang Steven R, Higgins Alexandra, Castillo Almeida Natalia E, LaPlant Betsy, Maurer Matthew J, Ansell Stephen M, Witzig Thomas E, Thanarajasingam Gita, Bennani N Nora

机构信息

Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

出版信息

Leuk Lymphoma. 2021 Jan;62(1):247-251. doi: 10.1080/10428194.2020.1827250. Epub 2020 Oct 6.

DOI:10.1080/10428194.2020.1827250
PMID:33021136
Abstract
摘要

相似文献

1
Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors.抗生素使用对接受免疫检查点抑制剂治疗的霍奇金淋巴瘤患者结局的影响。
Leuk Lymphoma. 2021 Jan;62(1):247-251. doi: 10.1080/10428194.2020.1827250. Epub 2020 Oct 6.
2
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma.检查点抑制剂与霍奇金淋巴瘤和非霍奇金淋巴瘤
Curr Hematol Malig Rep. 2018 Dec;13(6):543-554. doi: 10.1007/s11899-018-0484-4.
3
Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.用于霍奇金淋巴瘤和非霍奇金淋巴瘤的检查点抑制剂及其他免疫疗法。
Curr Treat Options Oncol. 2016 Jun;17(6):31. doi: 10.1007/s11864-016-0401-9.
4
PD-1 inhibitors in patients with Hodgkin lymphoma.霍奇金淋巴瘤患者中的程序性死亡受体1（PD-1）抑制剂
Eur J Cancer. 2022 Mar;164:114-116. doi: 10.1016/j.ejca.2021.06.059. Epub 2021 Aug 26.
5
Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them.霍奇金淋巴瘤和非霍奇金淋巴瘤中的免疫检查点抑制剂：作用机制及应用时机
Expert Rev Hematol. 2016 Nov;9(11):1007-1009. doi: 10.1080/17474086.2016.1242404. Epub 2016 Oct 17.
6
Checkpoint Inhibition: Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors in Hodgkin Lymphoma.检查点抑制：霍奇金淋巴瘤中的程序性细胞死亡蛋白1和程序性细胞死亡蛋白1配体抑制剂
Cancer J. 2016 Jan-Feb;22(1):17-22. doi: 10.1097/PPO.0000000000000164.
7
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.体质量指数与接受免疫检查点抑制剂纳武利尤单抗治疗的霍奇金淋巴瘤患者的生存结局和免疫相关不良事件无关。
J Transl Med. 2021 Dec 1;19(1):489. doi: 10.1186/s12967-021-03134-4.
8
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma.抗 PD-1 阻断失败后复发难治性霍奇金淋巴瘤的化疗疗效。
Cancer Med. 2020 Nov;9(21):7830-7836. doi: 10.1002/cam4.3262. Epub 2020 Sep 2.
9
Back to life with checkpoint inhibitors in Hodgkin lymphoma.霍奇金淋巴瘤中免疫检查点抑制剂带来的重生
J Oncol Pharm Pract. 2018 Mar;24(2):139-142. doi: 10.1177/1078155216685166. Epub 2016 Dec 20.
10
Clinical, Imaging Findings, Responses, and Outcomes of Patients With Classical Hodgkin Lymphoma and Non-Hodgkin Lymphoma Undergoing Immune Checkpoint Inhibitor Therapy: A Single-Institution Experience.接受免疫检查点抑制剂治疗的经典型霍奇金淋巴瘤和非霍奇金淋巴瘤患者的临床、影像学表现、反应及预后：单中心经验
J Comput Assist Tomogr. 2020 Jul/Aug;44(4):619-626. doi: 10.1097/RCT.0000000000001043.

引用本文的文献

1
Influence of the gut microbiome on lymphoma treatment: current evidence and future therapeutic directions.肠道微生物群对淋巴瘤治疗的影响：当前证据与未来治疗方向
Ther Adv Med Oncol. 2025 Aug 19;17:17588359251363207. doi: 10.1177/17588359251363207. eCollection 2025.
2
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review.淋巴瘤中免疫检查点阻断的疗效及反应生物标志物：一项叙述性综述
Biomedicines. 2023 Jun 15;11(6):1720. doi: 10.3390/biomedicines11061720.
3
A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors.
一项评估抗生素使用对接受免疫检查点抑制剂治疗的癌症患者临床结局影响的系统评价和荟萃分析。
Front Oncol. 2023 Mar 2;13:1075593. doi: 10.3389/fonc.2023.1075593. eCollection 2023.
4
Defining the Role of the Gut Microbiome in the Pathogenesis and Treatment of Lymphoid Malignancies.定义肠道微生物组在淋巴恶性肿瘤发病机制和治疗中的作用。
Int J Mol Sci. 2023 Jan 24;24(3):2309. doi: 10.3390/ijms24032309.
5
Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma.多发性骨髓瘤患者自体干细胞移植后肠道微生物组的扰动及其与结局的关联。
Leuk Lymphoma. 2023 Jan;64(1):87-97. doi: 10.1080/10428194.2022.2131410. Epub 2022 Oct 11.
6
The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors.抗生素使用对接受免疫检查点抑制剂治疗的癌症患者临床特征和生存结局的影响。
Front Immunol. 2022 Jul 28;13:968729. doi: 10.3389/fimmu.2022.968729. eCollection 2022.